美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

健康照護類股ETF-SPDR

156.32

-1.3900-0.88%

盤後：156.490.1700+0.11%16:36 EST

成交量：1,181.99萬

成交額：18.50億

市值：418.18億

市盈率：-11.00

高：158.15

開：157.57

低：156.03

收：157.71

52周最高：160.59

52周最低：127.35

股本：2.68億

流通股本：2.68億

量比：0.66

換手率：4.42%

股息：2.48

股息率：1.58%

每股收益(TTM):-14.2170

每股收益(LYR):-14.2170

淨資產收益率：-9.22%

總資產收益率：1.03%

市淨率：1.22

市盈率(LYR):-11.00

資料載入中...

總覽公司新聞資訊公告

概念

高盛持倉+0.54%

ETF&股票定投概念+0.55%

資金流向

資金流入：

資金流出：

新聞資訊

大行評級丨高盛：內地醫療健康板塊的強勁趨勢將延續，對CDMO企業看好轉趨建設性

【投孖展動態】安濟盛生物D輪孖展，孖展額1.3億美元，投資方為Frazier Life Sciences、Venrock Healthcare Capital Partners等

2026年度南昌市靈活就業人員繳納醫保指南出爐

一批製造公眾用藥焦慮，引導購買高端醫療保險的賬號被依法處置

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/XLV"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照護類股ETF-SPDR","latestPrice":156.32,"timestamp":1770670800000,"preClose":157.71,"halted":0,"volume":11819897,"hourTrading":{"tag":"盘后","latestPrice":156.49,"preClose":156.32,"latestTime":"16:36 EST","volume":13549,"amount":2118911.98669,"timestamp":1770672979830,"change":0.17,"changeRate":0.001088,"amplitude":0.001535},"delay":0,"changeRate":-0.008813645298332475,"floatShares":267515324,"shares":267515324,"eps":-14.217021,"marketStatus":"盤後交易","change":-1.39,"latestTime":"02-09 16:37:12 EST","open":157.57,"high":158.15,"low":156.03,"amount":1850188098.43902,"amplitude":0.013442,"askPrice":156.52,"askSize":1,"bidPrice":156.35,"bidSize":31,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":157.71,"sharesOutstanding":267515324,"nav":157.697414,"aum":42186474890.19,"dividendRate":0.015839,"bidAskSpread":0.000069,"preHourTrading":{"tag":"盘前","latestPrice":157.66,"preClose":157.71,"latestTime":"09:29 EST","volume":7983,"amount":1260624.18897,"timestamp":1770647357343,"change":-0.05,"changeRate":-0.000317,"amplitude":0.006507},"postHourTrading":{"tag":"盘后","latestPrice":156.49,"preClose":156.32,"latestTime":"16:36 EST","volume":13549,"amount":2118911.98669,"timestamp":1770672979830,"change":0.17,"changeRate":0.001088,"amplitude":0.001535},"volumeRatio":0.655666,"optionData":{"bulkOrders":[{"symbol":"XLV","call":false,"expireDate":1773979200000,"strike":"150.0","timestamp":1770652291721,"price":1.02,"volume":3000,"amount":306000,"type":"-"}]},"impliedVol":0.1652,"impliedVolPercentile":0.4104},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":267515324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.655666,"shares":267515324,"dividePrice":2.476,"high":158.15,"amplitude":0.013442,"preClose":157.71,"low":156.03,"week52Low":127.35,"pbRate":"1.22","psRate":"63.49","week52High":160.59,"institutionHeld":0.7846,"latestPrice":156.32,"committee":0.9375,"eps":-14.217021,"divideRate":0.015839,"volume":11819897,"delay":0,"ttmEps":-14.217021,"open":157.57,"prevYearClose":154.8,"prevWeekClose":157.71,"prevMonthClose":154.74,"prevQuarterClose":154.8,"fiveDayClose":155.69,"twentyDayClose":157.31,"sixtyDayClose":150.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XLV","amount":0.564539,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XLV","amount":0.621655,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.236696,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.285214,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610021215","title":"大行評級丨高盛：內地醫療健康板塊的強勁趨勢將延續，對CDMO企業看好轉趨建設性","url":"https://stock-news.laohu8.com/highlight/detail?id=2610021215","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610021215?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 10:47","pubTimestamp":1770605223,"startTime":"0","endTime":"0","summary":"高盛发表研报指，去年内地医疗健康板块的强劲趋势将延续至今年，但投资者考虑估值时纳入更多研发管线的价值，因此，股份交易时更多基于企业的实际执行能力，而非单纯的授权交易预期。今年要获得超越行业的回报，更依赖于关键数据公布、实际成交，以及盈利兑现或转折点的能见度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260209/32006893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["XLV","159760","CDMO"],"gpt_icon":0},{"id":"2609504579","title":"【投孖展動態】安濟盛生物D輪孖展，孖展額1.3億美元，投資方為Frazier Life Sciences、Venrock Healthcare Capital Partners等","url":"https://stock-news.laohu8.com/highlight/detail?id=2609504579","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609504579?lang=zh_tw&edition=fundamental","pubTime":"2026-02-08 20:03","pubTimestamp":1770552185,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于2月4日公布的信息整理，安济盛生物医药技术(广州)有限公司D轮融资，融资额1.3亿美元，参与投资的机构包括Frazier Life Sciences，Venrock Healthcare Capital Partners，Ascenta Capital，BlackRock Innovation Capital，BVF，Logos Capital，RA Capital Management，威灵顿，Bain Capital Life Sciences，Elikon Venture，Janus Henderson，三正健康，高瓴资本，君联资本，晨兴创投，奥博资本，泰福资本，涌铧投资。安济盛生物医药技术(广州)有限公司成立于2018年6月,地处广州科学城，是一家专注于骨骼肌肉关节等疾病新药研发的跨国研发企业。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260208/32006199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["XBI","XLV","HCCCU","BK4588","BK4581","BK4585","LABU"],"gpt_icon":0},{"id":"2609254915","title":"2026年度南昌市靈活就業人員繳納醫保指南出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2609254915","media":"南昌发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609254915?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 14:30","pubTimestamp":1770445800,"startTime":"0","endTime":"0","summary":"灵活就业人员自愿参加职工医保的，应当按年一次性缴纳全年费用，不允许按月缴费，待遇享受按有关规定执行。职工医保停保后转为以灵活就业人员身份参保的，可从停保次月一次性缴费至当年的12月31日。当年已参加居民医保并缴费的，不得中途再以灵活就业人员身份参加当年职工医保。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-02-07/doc-inhkykzi4247953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LABU","XLV","BK4588","BK4581","XBI"],"gpt_icon":0},{"id":"2609459639","title":"一批製造公眾用藥焦慮，引導購買高端醫療保險的賬號被依法處置","url":"https://stock-news.laohu8.com/highlight/detail?id=2609459639","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609459639?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:23","pubTimestamp":1770380580,"startTime":"0","endTime":"0","summary":"来源：北京商报\n　　2月6日，北京商报记者了解到，近期，中央网信办会同国家医保局深入整治涉医药集中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。根据通报的典型案例，微博账号“成都XXX”，抖音账号“琼波XX”“亮晶晶的XX”等，歪曲国家政策，编造“进口药集体退出中国”等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨在制造公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购药。涉及的账号已被依法依约采取处置措施。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：曹睿潼","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-06/doc-inhkwssf2096736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4581","LABU","BK4585","BK4588","XLV"],"gpt_icon":0}],"pageSize":4,"totalPage":34,"pageCount":1,"totalSize":135,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XLV\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"高盛持倉","bkCode":"BK4581","id":"package_us_concept_gscc","changeRate":0.005354},{"market":"US","name":"ETF&股票定投概念","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.00546},{"market":"US","name":"碎股","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.005555}]}}